NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT03852823 2021-04-30Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursCSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 1 Unknown192 enrolled
NCT02812875 2020-06-26A Study of CA-170 (Oral PD-L1, PD-L2 and VISTA Checkpoint Antagonist) in Patients With Advanced Tumors and LymphomasCuris, Inc.Phase 1 Completed71 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00375245 2014-01-17Rapamycin With Grapefruit Juice for Advanced MalignanciesUniversity of ChicagoPhase 1 Completed41 enrolled
NCT00006246 2009-10-07Busulfan in Treating Children and Adolescents With Refractory CNS CancerPediatric Brain Tumor ConsortiumPhase 1 Completed28 enrolled